Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas

ABSTRACT Background Gastroenteropancreatic poorly differentiated neuroendocrine carcinomas (GEP‐NECs) are aggressive cancers where cytotoxic chemotherapy is the backbone of treatment. While the addition of immunotherapy with immune checkpoint inhibitors (IOs) to chemotherapy is recommended for lung...

Descripció completa

Dades bibliogràfiques

Autors principals:	Rushabh Gujarathi, Samantha Kwock, Faith Abodunrin, Namrata Setia, Xavier M. Keutgen, Chih‐Yi Liao
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-04-01
Col·lecció:	Cancer Medicine
Matèries:	chemotherapy immunotherapy ncdb neuroendocrine carcinomas neuroendocrine tumors
Accés en línia:	https://doi.org/10.1002/cam4.71809
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!